Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reimer

Showing results (121-130 of 153) with videos related to

Pageof 16
Sort By:
European Journal of Haematology|April 4, 2017
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsEMarc-Andrea Baertsch, Jana Schlenzka, Katharina Lisenko, et al.
European Radiology|September 18, 2025
Safety and evidence of CO<sub>2</sub> as a vascular contrast agent as an alternative to iodine-based contrast media in vascular procedures: a systematic review by the ESUR Contrast Medium Safety CommitteeRobert P Wawer Matos Reimer, Peter Reimer, Andreas H Mahnken, et al.
European Radiology|May 27, 2025
Hypersensitivity reactions to contrast media: Part 1. Management of immediate and non-immediate hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety CommitteeAart J van der Molen, Annick A J M van de Ven, Francisco Vega, et al.
European Radiology|May 27, 2025
Hypersensitivity reactions to contrast media: Part 2. Prevention of recurrent hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety CommitteeAart J van der Molen, Annick A J M van de Ven, Francisco Vega, et al.
European Radiology|December 7, 2007
Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesionsRenate Hammerstingl, Alexander Huppertz, Josy Breuer, et al.
Clinical Chemistry and Laboratory Medicine|December 5, 2023
Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science CommitteeAart J van der Molen, Johannes G Krabbe, Ilona A Dekkers, et al.
European Radiology|May 15, 2026
Type, severity, frequency and management of adverse reactions associated with ultrasound contrast agents: a systematic review and meta-analysisHonoria Ocagli, Laura Romanini, Adea Llane, et al.
Investigative Radiology|January 27, 2009
Comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine-enhanced magnetic resonance imaging in five hundred seventy-two patients with known or suspected liver lesions: results of a multicenter, double-blind, interindividual, randomized clinical phase-III trialRenate Hammerstingl, Gerhard Adam, Juan-Ramon Ayuso, et al.
European Radiology|December 7, 2023
Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science CommitteeAart J van der Molen, Johannes G Krabbe, Ilona A Dekkers, et al.
European Radiology|August 21, 2003
Gadobutrol-enhanced moving-table magnetic resonance angiography in patients with peripheral vascular disease: a prospective, multi-centre blinded comparison with digital subtraction angiographyAnnette Hentsch, Manuela A Aschauer, Jörn O Balzer, et al.
Pageof 16

Showing results (121-130 of 153) with videos related to

Sort By:
Pageof 16
European Journal of Haematology|April 4, 2017
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsEMarc-Andrea Baertsch, Jana Schlenzka, Katharina Lisenko, et al.
European Radiology|September 18, 2025
Safety and evidence of CO<sub>2</sub> as a vascular contrast agent as an alternative to iodine-based contrast media in vascular procedures: a systematic review by the ESUR Contrast Medium Safety CommitteeRobert P Wawer Matos Reimer, Peter Reimer, Andreas H Mahnken, et al.
European Radiology|May 27, 2025
Hypersensitivity reactions to contrast media: Part 1. Management of immediate and non-immediate hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety CommitteeAart J van der Molen, Annick A J M van de Ven, Francisco Vega, et al.
European Radiology|May 27, 2025
Hypersensitivity reactions to contrast media: Part 2. Prevention of recurrent hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety CommitteeAart J van der Molen, Annick A J M van de Ven, Francisco Vega, et al.
European Radiology|December 7, 2007
Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesionsRenate Hammerstingl, Alexander Huppertz, Josy Breuer, et al.
Clinical Chemistry and Laboratory Medicine|December 5, 2023
Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science CommitteeAart J van der Molen, Johannes G Krabbe, Ilona A Dekkers, et al.
European Radiology|May 15, 2026
Type, severity, frequency and management of adverse reactions associated with ultrasound contrast agents: a systematic review and meta-analysisHonoria Ocagli, Laura Romanini, Adea Llane, et al.
Investigative Radiology|January 27, 2009
Comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine-enhanced magnetic resonance imaging in five hundred seventy-two patients with known or suspected liver lesions: results of a multicenter, double-blind, interindividual, randomized clinical phase-III trialRenate Hammerstingl, Gerhard Adam, Juan-Ramon Ayuso, et al.
European Radiology|December 7, 2023
Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science CommitteeAart J van der Molen, Johannes G Krabbe, Ilona A Dekkers, et al.
European Radiology|August 21, 2003
Gadobutrol-enhanced moving-table magnetic resonance angiography in patients with peripheral vascular disease: a prospective, multi-centre blinded comparison with digital subtraction angiographyAnnette Hentsch, Manuela A Aschauer, Jörn O Balzer, et al.
Pageof 16